Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 5

1.

prasugrel

A novel platelet inhibitor approved for the reduction of thrombotic cardiovascular events in patients with acute coronary syndrome. Prasugrel produces inhibition of platelet aggregation by binding to receptors for ADP on the surface of platelets. [from NCI]

MedGen UID:
301183
Concept ID:
C1620287
Pharmacologic Substance
2.

thienopyridine

MedGen UID:
249076
Concept ID:
C1120149
Pharmacologic Substance
3.

Thienopyridine Antiplatelet Agent

MedGen UID:
442927
Concept ID:
C2825216
Pharmacologic Substance
4.

Thienopyridines

A class of agents that target at platelet ADP receptor or purinergic receptor P2RY12 with antiplatelet activity. [from NCI]

MedGen UID:
423565
Concept ID:
C2936588
Pharmacologic Substance
5.

Antiplatelet Agents

An agent that inhibits platelet aggregation and reduces coagulation in the circulatory system. [from NCI]

MedGen UID:
43245
Concept ID:
C0085826
Pharmacologic Substance

Display Settings:

Format

Send to:

Choose Destination

Supplemental Content

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...